Search

Your search keyword '"Raj Rajagovindan"' showing total 9 results
Start Over Author "Raj Rajagovindan" Topic health policy
9 results on '"Raj Rajagovindan"'

1. Concordance of CSF biomarkers with amyloid PET at baseline in EMERGE/ENGAGE, phase 3 studies of aducanumab in patients with early Alzheimer’s disease

Author

Carrie E. Rubel, Laura Nisenbaum, Tianle Chen, Gersham Dent, Kyle Fraser, Danielle Graham, Katie Harrison, Ping He, Annie M Racine, Raj Rajagovindan, John Beaver, and Samantha Budd Haeberlein

Subjects
Psychiatry and Mental health, Cellular and Molecular Neuroscience, Developmental Neuroscience, Epidemiology, Health Policy, Neurology (clinical), Geriatrics and Gerontology
Published
2022

2. Exploratory evaluation of 18F‐MK‐6240 tau PET positivity in TANGO phase 2 clinical trial of gosuranemab (BIIB092) in Mild Cognitive Impairment and mild Alzheimer’s disease

Author

Annie M Racine, Jessica A. Collins, Jonathan M DuBois, John Seibyl, Jessica Kong, Yumeng Li, John O'Gorman, Sara J. Makaretz, Stephanie Jones, Danielle Graham, Raj Rajagovindan, Melanie Shulman, and Samantha Budd Haeberlein

Subjects
Psychiatry and Mental health, Cellular and Molecular Neuroscience, Developmental Neuroscience, Epidemiology, Health Policy, Neurology (clinical), Geriatrics and Gerontology
Published
2022

3. Subgroup analyses of the amyloid PET substudies from EMERGE and ENGAGE, phase 3 clinical trials evaluating aducanumab in patients with early Alzheimer’s disease

Author

Raj Rajagovindan, Tianle Chen, Hao Wu, Ying Tian, Laura Nisenbaum, Carmen Castrillo‐Viguera, Ping He, and Samantha Budd Haeberlein

Subjects
Psychiatry and Mental health, Cellular and Molecular Neuroscience, Developmental Neuroscience, Epidemiology, Health Policy, Neurology (clinical), Geriatrics and Gerontology
Published
2021

4. Reductions in biomarkers of Alzheimer’s disease pathophysiology following treatment with aducanumab were associated with slowing in clinical decline

Author

Raj Rajagovindan, Tianle Chen, Laura Nisenbaum, Ying Tian, Kumar Kandadi Muralidharan, Gersham Dent, Ping He, Carmen Castrillo‐Viguera, and Samantha Budd Haeberlein

Subjects
Psychiatry and Mental health, Cellular and Molecular Neuroscience, Developmental Neuroscience, Epidemiology, Health Policy, Neurology (clinical), Geriatrics and Gerontology
Published
2021

6. Baseline characteristics from TANGO: Phase 2 study to evaluate gosuranemab (BIIB092) in patients with early Alzheimer’s disease

Author

Annie M. Racine, Melanie B Shulman, Louis Viollet, Philipp von Rosenstiel, John O'Gorman, Tracy Mirabile, Elena Ratti, Dominic M. Walsh, Raj Rajagovindan, Danielle Graham, Jessica Kong, Stephanie Jones, and Daniela Ramirez Schrempp

Subjects
medicine.medical_specialty, Epidemiology, business.industry, Health Policy, Phases of clinical research, Disease, Clinical trial, Psychiatry and Mental health, Cellular and Molecular Neuroscience, Developmental Neuroscience, Baseline characteristics, Internal medicine, Medicine, In patient, Neurology (clinical), Geriatrics and Gerontology, business
Published
2020

7. Emerge and Engage topline results: Phase 3 studies of aducanumab in early Alzheimer’s disease

Author

Christian von Hehn, Spyros Chalkias, Laura Nisenbaum, Ying Zhu, Ivan Nestorov, Samantha Budd Haeberlein, Kumar Kandadi Muralidharan, LeAnne Skordos, Ying Tian, Katie Harrison, Shuang Wu, Craig Mallinckrodt, Tianle Chen, Raj Rajagovindan, Alfred Sandrock, and Gersham Dent

Subjects
Epidemiology, business.industry, Health Policy, Disease, Developmental psychology, Psychiatry and Mental health, Cellular and Molecular Neuroscience, Developmental Neuroscience, Phase (matter), Medicine, Neurology (clinical), Aducanumab, Geriatrics and Gerontology, business
Published
2020

8. P3‐033: RANDOMIZED, DOUBLE‐BLIND, PLACEBO‐CONTROLLED STUDY TO ASSESS TREATMENT OF BIIB092 IN SUBJECTS WITH EARLY ALZHEIMER'S DISEASE: TANGO PHASE 2 STUDY DESIGN

Author

Kumar Kandadi Muralidharan, Michael Grundman, Elena Ratti, Chris Henderson, Bjoern Sperling, Danielle Graham, Jessica Kong, Samantha Budd Haeberlein, Sue T. Griffin, John O'Gorman, Anirvan Ghosh, Li Zhang, Judith Jaeger, Raj Rajagovindan, and Tina Olsson

Subjects
0301 basic medicine, medicine.medical_specialty, Epidemiology, business.industry, Health Policy, Placebo-controlled study, Phases of clinical research, Disease, Double blind, 03 medical and health sciences, Psychiatry and Mental health, Cellular and Molecular Neuroscience, 030104 developmental biology, 0302 clinical medicine, Developmental Neuroscience, Internal medicine, Medicine, Neurology (clinical), Geriatrics and Gerontology, business, 030217 neurology & neurosurgery
Published
2018

9. P1-377: BIIB092 DOES NOT INTERFERE WITH RADIOLABELED MK6240 BINDING TO NEUROFIBRILLARY TANGLES: RESULTS FROM IN VITRO COMPETITION BINDING STUDY IN ALZHEIMER'S BRAIN TISSUE SECTIONS

Author

Roser Farre Garros, Nicolas Salem, Sara Girmay, Abha Yadav, Lisa Wells, Heike Hering, Paul H. Weinreb, Richelle Sopko, and Raj Rajagovindan

Subjects
Epidemiology, Chemistry, Health Policy, media_common.quotation_subject, Brain tissue, In vitro, Competition (biology), Cell biology, Psychiatry and Mental health, Cellular and Molecular Neuroscience, Developmental Neuroscience, Binding study, Neurology (clinical), Geriatrics and Gerontology, media_common
Published
2019

Catalog

Books, media, physical & digital resources
See catalog results